The healthcare-associated infectious disease diagnostics market is expected to grow at a CAGR of over 8% during the period 2018–2024

NEXT STORY
Opthea Presents Additional Data from OPT-302 Phase 2b Wet AMD Trial at the Ophthalmology Innovation Summit in San Francisco
PREV STORY
The global microbial identification panel market is expected to reach US$ 3,873.1 Mn in 2027 from US$ 2,288.7 Mn in 2018
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Bellerophon to Present Positive Clinical Data on INOpulse® at the American Thoracic Society 113th International Conference

Data Show that INOpulse was Associated with Clinically Meaningful Improvements in Hemodynamics and Exercise ...

author_avatar
NASDAQ Market News

Roche to present pivotal data for satralizumab in neuromyelitis optica spectrum disorder and six-year OCREVUS data in multiple sclerosis at ECTRIMS

author_avatar
NASDAQ Market News

Helsinn initiates two new global Phase III studies with anamorelin

author_avatar
NASDAQ Market News